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ABSTRACT 
 Extracellular matrix (ECM) remodeling is crucial for the development and 
maintenance of multicellular organisms.  Degradation of ECM components occurs 
through the activity of matrix metalloproteinases (MMPs) and their inhibitors.  
Reversion-inducing cysteine-rich protein with Kazal motifs (RECK) gene encodes a 
membrane-anchored protein and plays an important role in mediating ECM remodeling 
by inhibiting MMPs.  To date, few in vivo studies exist examining RECK during 
development.  The present study focuses on cloning and examining the expression of 
RECK during early Xenopus laevis development.  A mature cDNA clone of the RECK 
gene was generated.  RT-PCR, in situ hybridization, and immunohistochemistry were 
used to examine the expression of RECK during development.  RECK expression was 
low during gastrulation but increased during neurulation and into organogenesis.  
Furthermore, RECK was localized to the anterior and dorsal sides of the developing 
embryo.  These results suggest an important role for RECK during late ECM remodeling 
events, such as neurulation.     
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1.1 Extracellular matrix dynamics 
 The extracellular matrix (ECM) is an extensive network of interacting 
macromolecules that surrounds cells in tissues.  The ECM is primarily composed of 
fibrous structural proteins such as collagens and fibronectin; however, it also sequesters a 
variety of important signaling molecules such as cytokines and growth factors.  As such, 
the ECM not only provides structural support to cells in tissue but also regulates cell 
growth, survival, migration, and differentiation (Nyalendo et al., 2007).  Changes in cell-
cell and cell-ECM contacts as well as the release of sequestered proteins occur through 
cleavage and remodeling of the ECM.  These processes are crucial for proper 
development and maintenance of multicellular organisms.  Changes and remodeling of 
the ECM occur through the action of a group of extracellular proteases called matrix 
metalloproteinases (MMPs) (Takino et al., 1995). 
1.2 Matrix Metalloproteinases 
 MMPs are a large family of zinc-dependent endopeptidases.  Twenty-four 
vertebrate MMPs have been characterized, which together are capable of cleaving all 
components of the ECM (Visse and Nagase, 2003).  MMPs are classified into 2 
categories: secreted and membrane-type (MT) MMPs (reviewed in Jiang and Pei, 2003).  
Most MMPs are secreted, and are released into the ECM as inactive zymogens (pro-
MMPs).  Once activated through the removal of their prodomain, secreted MMPs can 
directly cleave ECM proteins as well as release cytokines, growth factors, and other 
ECM-bound signaling molecules.  As their name describes, membrane-type MMPs are 
bound to the cell surface.  MT-MMPs are shuttled to the plasma membrane in an already 
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active form; their prodomains are removed by the endoprotease furin within the Golgi 
during secretion.  MT-MMPs not only cleave ECM proteins but also activate other 
secreted pro-MMPs (Wang et al., 2004). Once activated, the family of MMP molecules 
can collectively cleave all components of the ECM.  However, different MMPs have 
specific substrate specificities, and thus carry out separate functions during ECM 
remodeling depending on the composition of the ECM (Visse and Nagase, 2003).  For 
example, MMP-2 is a potent gelatinase whose role is to degrade collagen type IV, a 
major component of the ECM (Jiang and Pei, 2003), whereas MT1-MMP can cleave a 
number of substrates including collagens I, II, and III, but it is unique in that it has the 
ability to activate pro-MMP-2 (Visse and Nagase, 2003).     
 In adults, ECM remodeling is limited.  Uncontrolled cleavage of the ECM is often 
associated with tumor progression and metastasis.  Studies have identified a correlation 
between high MMP activity and tumor progression as a result of excessive ECM 
degradation (Visse and Nagase, 2003).  During development, the extracellular matrix 
undergoes extensive remodeling to allow processes such as gastrulation and 
organogenesis to occur.  As such, MMPs are highly expressed during development 
(Alexander et al., 1996).  However, aberrant up-regulation of MMPs has been associated 
with developmental defects and death.  For example, Damjanovski et al. (2001) generated 
transgenic frog embryos that overexpressed either MMP-9 or -11 and found that 
overexpression of these MMPs resulted in embryonic lethality in a dose-dependent 
manner.  Therefore, it is crucial that MMP activity be tightly regulated.  Regulation of 
MMP activity occurs via a number of different inhibitors, including tissue inhibitors of 
metalloproteinases (TIMPs) (Baker et al., 2004). 
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1.3 Tissue Inhibitors of Metalloproteinases 
TIMPs, endogenous inhibitors of MMPs, are a family of four secreted proteins.  
TIMP proteins are unique in that they contain structurally and functionally distinct N- and 
C-terminal domains.  The N-terminal domain binds non-covalently to the active site of 
MMPs and inhibits MMP catalytic activity (Gomis-Ruth et al., 1997).  This leaves the C-
terminal domain free to carry out other functions, including cell signaling via an ability to 
bind to distinct cell surface partners (Visse and Nagase, 2003).  All four TIMPs are 
capable of inhibiting the activity of distinct members of the MMP family via their N-
terminal domain, however, they function differently at their C-terminal domains.  For 
example, TIMP-1 has been shown to inhibit apoptosis by binding to CD63 and β1 
integrin receptors on the cell surface (Chirco et al., 2006), whereas TIMP-2 has been 
shown to inhibit cell migration by binding to α3β1 integrins on the cell surface (Oh et al., 
2004). 
A delicate balance between MMP and TIMP levels is crucial for proper 
development to occur.  As such, TIMPs are also expressed during development in order 
to regulate MMP activity (Alexander et al., 1996).  Any shift in balance can disrupt 
development.  For example, overexpression of TIMP-2 or -3 during early frog 
development both resulted in severe developmental defects (Nieuwesteeg et al., 2012).  
Until recently, TIMPs were thought to be the main regulators of MMPs, however, a new 
inhibitor of MMPs was also discovered, known as reversion-inducing cysteine-rich 
protein with Kazal motifs (RECK).   
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1.4 RECK structure 
 RECK was first discovered as a gene that induces flat cell morphology when 
expressed in ras-transformed mouse fibroblasts (Takahashi et al., 1998).  The RECK gene 
encodes a GPI-anchored protein with multiple epidermal growth factor (EGF)-like 
repeats and three serine-protease inhibitor-like domains.  These protease inhibitor-like 
domains are called Kazal motifs as they follow the general amino acid sequence of a 
Kazal motif (reviewed in Rimphanitchayakit and Tassanakajon, 2010). RECK proteins 
also contain five repeats of a putative cystine knot motif and five asparagine residues that 
serve as potential glycosylation sites.  The N-terminal region of RECK contains a 
hydrophobic domain which serves as a signal peptide that is cleaved in the mature 
protein.  The C-terminal region of RECK also contains a hydrophobic domain which 
serves as a signal for GPI-anchoring to the membrane (Takahashi et al., 1998) (Figure 1).   
All mammalian RECK proteins that have been cloned to date are highly 
conserved at the amino acid level and share the same structure as outlined in Figure 1.  
Mammalian RECK proteins are 971 amino acids in length and weigh approximately 110 
kDa (Takahashi et al., 1998).  RECK has also been cloned from a variety of non-
mammalian vertebrate and invertebrate species and shows evolutionary conservation, 
however, Xenopus laevis RECK has not previously been cloned. 
1.5 RECK function in vitro     
Since its discovery in ras-transformed mouse fibroblasts, RECK quickly became 
known as a tumor suppressor protein.  As such, numerous studies have been carried out to 
determine  its   anti-invasive  properties.   In  vitro  studies  have  shown  that  RECK  can  
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Figure 1.  
Schematic representation of the full length RECK protein. Mammalian RECK is 971 
amino acids in length and contains a signal peptide on the N-terminus and a GPI-
anchoring domain on the C-terminus.  The N-terminal region of RECK contains a 
putative cysteine knot motif.  The middle portion of RECK contains 3 Kazal motifs 
(serine-protease inhibitor-like domains) and 2 epidermal growth factor (EGF)-like 





























negatively regulate three MMPs.  RECK can inhibit the secretion of MMP-9 and can 
directly inhibit the enzymatic activities of MMP-2 and MT1-MMP.  Interestingly, RECK 
can also inhibit the expression of MMP-9 (Oh et al., 2001; Takagi et al., 2009; Takahashi 
et al., 1998) (Figure 2).     
Although RECK mRNA is highly expressed in various human tissues, its 
expression is undetectable in many tumor-derived cell lines (Takahashi et al., 1998).  As 
such, RECK expression has been studied in various solid tumors, including breast cancer 
(Span et al., 2003), lung cancer (Takenaka et al., 2005), pancreatic cancer (Furumoto et 
al., 2001), and colorectal cancer (Takeuchi et al., 2004).  All of these studies arrived at 
the same conclusion: the more RECK is expressed, the better the prognosis is for the 
patient.  Futhermore, studies have shown that when RECK expression is restored in tumor 
cell lines invasiveness decreases (Oh et al., 2001; Takahashi et al., 1998; Simizu et al., 
2005; Chang et al., 2008).  Takahashi et al. (1998) generated stable transfectants of 
RECK-expressing fibrosarcoma cell lines and found that invasiveness decreased in 
RECK-expressing cells.  Moreover, Oh et al. (2001) found that re-expression of RECK in 
HT1080 cells tumors in mice repressed tumor angiogenesis.  Altogether, these results 
classify RECK as a tumor suppressor protein that can decrease invasiveness by inhibiting 
MMP activity. 
1.6 Regulation of RECK  
 Since its discovery, the majority of research characterizing RECK focuses on its 
ability to suppress tumor cell invasion.  However, more studies have arisen regarding 
how   RECK  is   regulated.   RECK   was  first   discovered   in   ras-transformed   mouse 
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Figure 2.  
Effects of RECK on MMPs. RECK is bound to the membrane through GPI-anchoring.  
RECK inhibits the secretion of pro-MMP-9 and directly inhibits the enzymatic activity of 
MT1-MMP and MMP-2, as well as inhibiting the expression of MMP-9.  MMP-2 and -9 
(gelatinases) are potent enzymes whose functions are associated with important 
developmental events and diseases.  MT1-MMP is an important cell surface MMP whose 























fibroblasts.  This suggests regulation by oncogenic signaling (Takahashi et al., 1998).  
More recently, Chang et al. (2004) revealed that RECK is regulated at the transcriptional 
level through Sp1-binding sites (GC boxes) located downstream of the transcriptional 
start site.  This binding site serves as a cis-element and is involved in repressing RECK 
expression.  Phosphorylation of Sp1 occurs by external signal-regulated kinase (ERK).  
Phosphorylated Sp1 and histone deacetylase (HDAC) 1 bind to the Sp1 binding site and 
repress RECK expression.  Furthermore, Liu et al. (2002) revealed that Trichostatin A, a 
histone deacetylase inhibitor known to suppress tumor invasion, was shown to activate 
the RECK promoter and cause a decrease in secreted MMP-2.   
 RECK has also been shown to be regulated at the post-translational level.  As 
mentioned previously, RECK contains five potential glycosylation sites.  Simizu et al. 
(2005) identified that three of the five glycosylated asparagine (Asn) residues of RECK 
are required to suppress tumor cell invasion.  Simizu et al. (2005) generated RECK 
mutants in which they replaced asparagine residues with glutamine residues.  Mutant and 
wild-type RECK genes were transfected into HT1080 cells and MMP-2 and -9 expression 
were subsequently assayed.  Results indicated that glycosylation of RECK Asn297 was 
required to inhibit MMP-9 secretion and glycosylation of RECK Asn352 was required to 
inhibit the activation of pro-MMP-2.  Furthermore, Simizu et al. (2005) correlated 
glycosylation of RECK with tumor cell invasion and found that glycosylation of RECK 
at Asn86, Asn297, and Asn352 was required to suppress HT1080 cell invasion. 
 Interestingly, RECK has also been shown to be regulated by another key player of 
ECM remodeling.  TIMP-2 is a well-characterized MMP inhibitor.  As described, TIMP-
2 can bind directly to MMPs in the ECM and inhibit their function.  Additionally, TIMP-
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2 can also indirectly up-regulate RECK, which in turn inhibits MMPs.  Specifically, 
TIMP-2 binds to α3β1 integrins on the surface of human endothelial cells, inactivates Src 
kinase through changes in paxillin (PAX) phosphorylation, and activates the small 
GTPase Rap1, which ultimately results in up-regulation of RECK (Oh et al., 2004) 
(Figure 3). 
1.7 Xenopus laevis as a model system  
The model organism used in this study is Xenopus laevis, the African clawed frog.  
Xenopus laevis is an ideal developmental model organism with which complex biological 
processes can be investigated.  Hundreds of embryos can be obtained from a single 
fertilization, development occurs rapidly, and embryos are large and easy to manipulate.  
Furthermore, fate maps and cell signaling cascades have been well characterized in X. 
laevis, making it an ideal model to study novel gene and protein functions during 
development. 
Xenopus laevis has long been used as a developmental model and undergoes 
typical embryological processes such as gastrulation (stage 10), formation and closure of 
the neural tube (stages 14 and 20, respectively), and organogenesis (stage 28 to 40) 
(Figure 4).  All of these processes involve large-scale cell movements and therefore 
require extensive remodeling of the ECM.  As previously mentioned, MMPs are highly 
expressed during development to regulate remodeling of the ECM in a temporal and 
tissue specific manner (Alexander et al., 1996).  However, a delicate balance between the 
levels of MMPs and their inhibitors is crucial for proper development to occur.  Since 




TIMP-2 induction of RECK expression.  TIMP-2 binds to α3β1 integrins on the cell 
surface, causing inactivation of Src through changes in paxillin (PAX) phosphorylation.  
Alteration in PAX phosphorylation mediates the activation of Rap1, ultimately resulting 
in increased expression of RECK, a membrane-anchored MMP inhibitor.  Enhanced 































Early developmental stages of X. laevis.  Development starts with a fertilized single-
celled egg.  Zygotic transcription begins at stage 9.  Gastrulation occurs at stage 10, 
forming the three germ layers: endoderm, ectoderm, and mesoderm as well as embryonic 
axes.  Neurulation begins at stage 14, which forms the neural tube by stage 20.  
Organogenesis is predominant at stage 28 and beyond during which the majority of the 
internal organs begin to develop.  Embryos become feeding tadpoles at about stage 40.  































that it plays important developmental roles as well. 
1.8 RECKing development 
 Since its discovery, most research characterizing RECK has been done in vitro in 
tumor-derived cell lines.  To date, few in vivo studies exist examining RECK function 
during development.  Oh et al. (2001) revealed that RECK-deficient mouse embryos died 
at embryonic day 10.5 because of abnormal vascularization, disrupted organogenesis, 
abdominal hemorrhaging, and smaller body size.  Histological examination of tissues in 
RECK-deficient embryos indicated abnormally large and deformed blood vessels.  The 
results implicated a role for RECK in vascular development, probably due to the ability 
of RECK to inhibit MMPs (Oh et al., 2001; Chandana, et al., 2010). 
 A more recent study analyzed RECK function during early zebrafish development 
and revealed the importance of RECK during the development of dorsal root ganglia 
(DRG).  DRG are derived from neural crest cells and are comprised of sensory neurons 
along with their associated glia.  Prendergast et al. (2012) examined zebrafish mutants 
unable to form DRG, termed sensory deprived (sdp), and discovered that this phenotype 
resulted due to a mutation in the RECK gene.  When RECK wasn’t expressed, the DRG 
failed to form.  Furthermore, RECK knockdown in zebrafish embryos also resulted in 
impairment of vascular integrity (Prendergast et al., 2012).  These results support the 
previous mouse knockout studies indicating RECK was involved in vascular 
development, and also reveal the importance of RECK in the development of DRG.  
Thus, RECK embryological data show that RECK plays a role associated with DRG 
formation and vascular development, processes that involve cell migration and ECM 
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remodeling.  However, a more comprehensive characterization of RECK during 
development is warranted.  Given its association with cell migration and ECM 
remodeling, embryonic processes such as gastrulation and neurulation require further 
examination.  Thus, a simple way to determine a possible role for RECK is by disrupting 
axis formation in the developing embryo.   
1.9 Axis perturbation in X. laevis embryos 
 Axis specific signaling pathways are well understood in X. laevis development.  
During development, the Wnt signaling pathway plays an important role in dorso-ventral 
patterning of the embryo (Reviewed in Sokol 1999).  The Wnt pathway is highly 
conserved and consists of a large number of proteins that altogether control cell-cell 
communication in multicellular organisms.  In the absence of Wnt, β-catenin is targeted 
for degradation through association with a destruction complex (Axin, Adenomatous 
Polyposis Coli (APC), and glycogen synthase kinase-3 β (GSK-3 β)) (Hart et al., 1998; 
Yost et al., 1996; Aberle et al., 1997).  However, when Wnt is present, it binds to cell 
surface receptors and induces a signaling cascade that activates Dishevelled (Dvl).  Dvl 
recruits Axin away from the destruction complex, inhibiting the degradation pathway and 
allowing β-catenin to accumulate in the cytosol and nucleus (Yamamoto et al., 1999).   
During embryonic development, the Wnt pathway is turned on in areas of the 
embryo fated to become dorsal.  However, if this pathway is turned on in other areas of 
the embryo not fated to become dorsal, then dorso-ventral patterning is disrupted and 
dorsalization is induced.  Dorsalization can be monitored by visualization of increases in 
the size of dorsal structures, such as the notochord and eyes, and with increased levels of 
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dorsal genes, such as chordin.  On the other hand, if the Wnt pathway is turned off in an 
area of the embryo fated to become dorsal, then ventralization is induced.  Thus, with 
ventralized embryos, there will be increased ventral structures and genes, and a 
concomitant decrease in dorsal structures and genes.      
When examining the complex roles a molecule may play during development, a 
simple approach is to perturb axis formation in early X. laevis embryos.  This method aids 
in dissecting out functions of genes in early development.  There are a variety of physical 
and chemical treatments that can be used to turn on/off the Wnt signaling pathway and 
thus perturb axis formation.  By doing so, a gene of interest can be studied to determine if 
its expression-associated effects are altered by the dorsalization/ventralization of the 
embryo.  Lithium chloride (LiCl) can be used on early frog embryos to induce 
dorsalization (Kao and Elinson, 1988), whereas ultraviolet light (UV) can be used to 
induce ventralization (Scharf and Gerhart, 1983).   
1.10 Dorsalization via lithium chloride treatment 
 LiCl induces dorsalization due to its effect on the Wnt pathway.  Lithium inhibits 
GSK-3 β, a member of the destruction complex.  This activates the Wnt pathway and 
prevents β-catenin from being degraded.  Accumulation of β-catenin in areas not fated to 
become dorsal disrupts dorso-ventral axis patterning and results in dorsalized embryos 
(Klein and Melton, 1996).  Thus, if the whole embryo is treated with LiCl, all tissues will 
be dorsalized.  The higher the dosage of LiCl, the more dorsalized the embryo will 
become.       
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1.11 Ventralization via ultraviolet light treatment 
 Dorso-ventral polarity is established during the first cell cycle in the forming frog 
zygote.  Following fertilization of an egg, a 30° rotation of the cortical cytoplasm relative 
to the cytoplasmic core, known as corticocytoplasmic rotation (CCR), occurs.  This 
process is mediated by a microtubule-associated motor and takes place on microtubules 
present on the vegetal side of the embryo (Elinson and Rowning, 1988).  Rotation results 
in the protection from degradation and accumulation of the dorsal determinant β-catenin 
on the future dorsal side of the embryo.  Thus, β-catenin localization begins the 
establishment of the dorso-ventral axis (Heasman 1997; Harland and Gerhart, 1997).  
When embryos are exposed to UV irradiation prior to completion of the first cell cycle, 
UV light depolarizes microtubules and prevents CCR. Without CCR, β-catenin is 
degraded everywhere and is not present to establish dorsal tissues.  Thus, ventralization 
of embryos occurs.   
1.12 Dorsoanterior index scale 
Sensitivity to axis perturbation treatments varies from embryo to embryo, causing 
a range of altered phenotypes to develop.  In order to characterize axis-perturbed 
embryos, a Dorsoanterior index scale (DAI) ranging from 1 to 10 was created by Kao and 
Elinson in 1998 and is currently the accepted standard.  A DAI of 0 is assigned to 
embryos that are completely ventralized and thus lack dorsoanterior structures.  Embryos 
assigned a DAI of 0 are comprised largely of yolk and have no head or tail present. A 
DAI of 10 is assigned to embryos that are completely dorsalized and thus have very 
enhanced dorsoanterior structures.  Embryos assigned a DAI of 10 have exaggerated 
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heads with bands of retinal pigment and cement glands.  Normal embryos fall in the 
middle of the scale and are assigned a DAI of 5.  
1.13 Hypothesis and investigation plan 
 RECK has been implicated to be an important regulator of ECM remodeling.  
Furthermore, during mouse and zebrafish development, RECK has been shown to play an 
important role during vascular development and neurulation.  I hypothesize that RECK 
will be differentially expressed throughout X. laevis development to regulate ECM 
remodeling.  
 To test this hypothesis, I cloned and sequenced the mature coding region of X. 
laevis RECK.  Subsequently, I examined the expression pattern of RECK during 
embryogenesis both temporally using semi-quantitative PCR and spatially using whole 
mount in situ hybridization and immunohistochemistry.  Furthermore, I perturbed axis 
formation in embryos by inducing either dorsalization or ventralization and examined if 
RECK transcript levels changed as a result.  Since few in vivo studies exist examining 
RECK expression during development, my project is the first detailed comprehensive 
characterization of RECK during X. laevis development.  Overall, this project provides a 
better understanding of RECK expression during development, and improves our 

























2.1 Animal care and rearing 
Adult male and female X. laevis were purchased from Xenopus 1, Inc. (Dexter, 
MI) and reared at room temperature in freshwater tanks on a 12-hour light/dark cycle. 
Fertilizations were carried out by injecting adult females with 300 µL of human chorionic 
gonadotropin (HCG; Chorulon, Whitby, ON) 18 hours prior to ovulation.  Adult males 
were sacrificed and dissected to remove the testes, which were stored for up to 1 week in 
1x Marc’s Modified Ringer solution (MMR; 88 mM NaCl, 1 mM KCl, 0.41 mM CaCl2, 
0.33 mM Ca(NO3)2, 0.82 mM MgSO4, 2 mM NaHCO3, 10 mM HEPES, pH 7.4) at 4°C. 
For fertilization, a small portion of a testis was minced and combined with eggs 
from an ovulating female in a Petri dish with 1 mL of 1x MMR.  After 2 minutes, the 
dish was flooded with 0.1x MMR.  Following cortical rotation (30 minutes post 
fertilization), embryos were de-jellied in a 3% cysteine solution (L-cysteine free base in 
0.1x MMR, pH 8.0) and then maintained in 0.1x MMR at room temperature until the 
desired developmental stage was reached.  Developing embryos were staged as 
previously described (Nieuwkoop and Faber, 1994).  All procedures were in compliance 
with the animal care standards set by The Canadian Council on Animal Care.                    
2.2 Polymerase chain reaction (PCR) amplification of the full length coding region 
of X. laevis RECK 
 In order to examine RECK expression during early X. laevis development, the 
RECK gene first needed to be cloned and sequenced.  However, X. laevis sequences are 
poorly annotated due to their pseudotetraploid genome.  As such, the online database of 
Xenopus tropicalis was used instead as this species is evolutionarily related to X. laevis.  
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Based on the X. tropicalis RECK sequence obtained online (accession number: 
XM_002938937.1), forward and reverse primers were engineered flanking the mature 
coding region of the RECK gene (Table 1).  Primers were also generated flanking a 
highly conserved region of RECK (the three Kazal motif domains) for subsequent 
experiments (Table 1).  Total RNA was isolated from adult X. laevis intestinal tissue (as 
mouse intestinal tissue is known to express RECK) using an RNeasy Kit (QIAGEN, 
Germantown, MD) according to manufacturer’s instructions.  First strand cDNA 
synthesis and PCR were performed on total RNA using qScriptTM Reverse Transcriptase 
(Quanta Biosciences, Gaithersburg, MD) and Kapa Hi-Fi Taq PCR Kit (Kapa 
Biosystems, Woburn, MA) according to manufacturer’s instructions.  The amplification 
program consisted of 94°C for 2 minutes, then cycling of 94°C for 30 seconds, 60°C for 
30 seconds, and 68°C for 2 minutes for 32 cycles, followed by 68°C for 10 minutes.  PCR 
products were visualized on a 1% TAE (40 mM Tris acetate, 1 mM EDTA) agarose gel 
and bands corresponding to the expected amplicon size were excised from the gel and 
purified using the QIAquick Gel Extraction Kit (QIAGEN) according to manufacturer’s 
instructions.  The purified amplicons were cloned into the pGEM-T vector (Promega, 
Madison, WI) and transformed into One Shot TOP 10 Chemically Competent E. coli 
cells (Life Technologies, Burlington, ON) and plated on Fastmedia Luria Bertani (LB) 
Agar Amp (Thermo Scientific, Waltham, MA).  The plates were incubated at 37°C for 24 
hours.  Colonies were picked, resuspended in 5 mL LB broth, and grown overnight at 
37°C.  Plasmids were isolated using a QIAprep Spin Miniprep Kit (QIAGEN).  Identity 
of the PCR products was confirmed by sequencing carried out at the DNA Sequencing 
Facility at Robarts Research Institute (London, ON).    
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Table 1.  
 
Oligonucleotide primers used for cloning the mature open reading frame of X. laevis 
RECK.    











5’GGATGTTTACAGGTCTACCC3’ 494 1904-1923 
3’ATGGACACTGCCAGGATGTT5’ 2378-2397 
 













2.3. Sequence analysis  
 To confirm its identity, X. laevis RECK sequence obtained in this study was 
compared to RECK sequences from a variety of other species.  Sequence analysis was 
carried out using RECK protein sequences obtained from the NCBI database 
(http://www.ncbi.nlm.nih.gov/pubmed/) as well as the predicted X. laevis RECK protein 
sequence.  RECK sequences along with the accession numbers used for comparison were 
from the following species:  Homo sapiens (NP_066934), Canis lupis familiaris 
(NP_001002985), Mus musculus (NP_057887), Gallus gallus (XP_418897), Xenopus 
laevis (cloned in this study), Oreochromis niloticus (XP_003457562), and Drosophila 
melanogaster (NP_648733).  Full-length RECK amino acid sequences were aligned 
using ClustalW2 Multiple Sequence Alignment web software at the European 
Bioinformatics Institute (EBI) site at (http://www.ebi.ac.uk/Tools/msa/clustalw2/) and 
given a score based on similarity.  The structural domains of RECK were determined 
using the SMART web software (http://smart.embl-heidelberg.de/).  All analyses were 
performed using default program settings. 
2.4 Reverse transcriptase PCR (RT-PCR) 
 To investigate temporal expression of RECK during early X. laevis development, 
semi-quantitative PCR was performed.  Total RNA was isolated from embryos at stages 
10, 18, 24, 32, 37, and 40 using an RNeasy Kit (QIAGEN).  First-strand cDNA synthesis 
and PCR were performed on total RNA using qScriptTM Reverse Transcriptase (Quanta 
Biosciences) and KapaTaq (Kapa Biosystems) according to manufacturer’s instructions.  
The amplification program consisted of 95°C for 2 minutes, then cycling of 95°C for 30 
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seconds, 60°C for 30 seconds, and 72°C for 30 seconds for 30 cycles (in the exponential 
phase).  The gene specific primers used for RT-PCR were as listed (Table 2).  PCR 
products were visualized on a 1% TAE agarose gel and quantified against elongation 
factor one alpha (EF1α) to calculate a percentage of expression (gene of interest over 
EF1α) with Quantity One software (version 4.4.1 Bio-Rad Laboratories, Hercules, CA).  
All quantified PCRs were repeated with three biological replicates.  
2.5 Synthesis of DIG-labeled RNA probes and whole mount in situ hybridization 
 To investigate spatial expression of RECK during early X. laevis development, 
whole mount in situ hybridization was performed.  Digoxigenin (DIG)-labeled anti-sense 
RNA probes were generated from the Kazal motifs cDNA clone (494 base pairs; Table 1) 
in pGEM-T vector (Promega) using SP6 RNA Polymerase and the DIG RNA Labeling 
Kit (SP6/T7; Roche, Laval, QC) according to the manufacturer’s instructions.  DIG-
labeled RECK RNA probes were purified using an RNeasy® Kit (QIAGEN).  DIG-labeled 
cardiac troponin 1 RNA probes were generously provided by Dr. Tom Drysdale 
(Western University).  Embryos from stages 23, 28, 35, and 38 were fixed in MEMFA 
(0.1M MOPS, 2mM EGTA, 1mM magnesium sulfate, 3.7% formaldehyde) buffer and 
stored in 100% methanol at -20°C.  For hybridization, embryos were rehydrated 
gradually with methanol and TTw (1x TBS 0.1% Tween-20 (Sigma, St. Louis, MO)) by 5 
minute incubations in 100% methanol, 75% methanol + 25% TTw, 50% methanol + 50% 
TTw, 25% methanol + 75% TTw, and 100% TTw.  They were then washed twice, 5 
minutes each, in TTw.  Unless otherwise stated, all steps were done at room temperature 
with a nutator.  Embryos were washed twice, 5 minutes each, in triethanolamine (Sigma).  
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Table 2.  
 
Oligonucleotide primers used for semi-quantitative PCR to characterize levels of 
developmental gene expression in X. laevis. 





Chordin 5’AACTGCCAGGACTGGATGGT 3’ 190 3201-3220 
3’GGCAGGATTTAGAGTTGCTTC 5’ 3391-3411 
EF1-α 5’CAGATTGGTGCTGGATATGC 3’ 268 1096-1115 
3’ACTGCCTTGATGACTCCTAG 5’ 1345-1364 
RECK 5’GGATGTTTACAGGTCTACCC3’ 147 1724-1744 
3’ATCTTTGGAGGAACAGAGCC5’  1851-1871 
TIMP-2 5’CCAAAGCCGTTACTGGAAAA3’ 218 261-280 
3’CATCACCATCGGCTTTACCT5’  460-479 
 
*Nucleotide position numbers refer to the following X. laevis sequences: chordin 










Acetic anhydride was added to triethanolamine in a 1:400  dilution  and  embryos  were  
again washed twice, 5 minutes each.  This step was monitored carefully, as embryos will 
degrade the next day if left too long.  Embryos were then washed five times, 5 minutes 
each, in TTw, followed by a 10 minute wash in 50% RNA hybridization buffer (50% 
formamide (Sigma), 5x SSC (45mM sodium citrate, 750mM NaCl, pH 7.0), 1 mg/mL 
Torula RNA, 1x Denhardt’s, 100 µg/mL Heparin, 0.1% Tween 20, 5 mM EDTA) + 50% 
TTw.  Embryos were allowed to settle in RNA hybridization buffer for 10 minutes, then 
fresh RNA hybridization buffer was added and embryos were prehybridized for 2 hours 
at 65°C.  The prehybridization buffer was replaced with fresh RNA hybridization buffer 
containing the probe (5-10 µg/mL) and embryos were incubated overnight at 65°C.  
Probes were saved the next day for future use.   
 RNA Hybridization buffer was gradually washed away with 10 minute washes of 
100% RNA hybridization buffer, 50% RNA hybridization buffer + 50% 2x SSC, and 
25% RNA hybridization buffer + 75% 2x SSC all done at 65°C.  Embryos were washed 
in 2x SSC twice for 30 minutes each at 37°C, followed by three washes, 45 minutes each, 
in 0.2x SSC at 65°C.  Embryos were washed for 10 minutes in TTw, followed by a 10 
minute wash in TBT (1x TBS + 0.1% Tween 20 + 1% BSA).  Embryos were blocked in 
20% heat-treated sheep serum in TBT for 1 hour.  Alkaline phosphatase conjugated DIG 
antibody (Roche) was added to the blocking solution at a 1:5000 dilution and embryos 
were incubated overnight at 4°C. 
 To remove antibody, embryos were washed 12 times, 30 minutes each, in TBT, 
and then washed for 10 minutes in alkaline phosphatase (100 mM Tris (pH 9.5), 50 mM 
magnesium chloride, 100 mM sodium chloride, 0.1% Tween 20) buffer.  BM purple AP 
  
30 
substrate, precipitating (NBT/BCIP ready to use) (Roche) was added to the alkaline 
phosphatase buffer and left until desired intensity was reached.  The reaction was stopped 
by gradually dehydrating with methanol and TTw by 5 minute incubations with 25% 
methanol + 75% TTw, 50% methanol + 50% TTw, 75% methanol + 25% TTw, and 
100% methanol.  Embryos were rehydrated again in methanol and TTw by 5 minute 
incubations in 75% methanol + 25% TTw, 50% methanol + 50% TTw, and 25% 
methanol + 75% TTw, and fixed for 20 minutes in MEMFA.  Embryos were washed 
three times, 5 minutes each, in TTw and then bleached for 4 hours in a bleaching solution 
(5% formamide (Sigma), 2.5% 20x SSC, 1% hydrogen peroxide in dH2O).  To remove 
bleaching solution, embryos were washed 3 times, 5 minutes each, in TTw.  For imaging, 
embryos were cleared in a 2:1 mixture of benzyl benzoate:benzyl alcohol to observe 
internal structures.  Embryos were visualized using an Olympus SZX9 microscope 
system and images were captured using a Nikon Coolpix 990 camera.  Images were 
processed using Adobe Photoshop CS5 Extended, version 12.0.   
2.6 Immunohistochemistry and fluorescence microscopy 
 To investigate the spatial expression of RECK proteins during early X. laevis 
development, immunohistochemistry was performed.  Embryos at stage 25 were fixed in 
3.7% paraformaldehyde in 1x PBS solution for 2 hours at room temperature and 
gradually dehydrated in ethanol.  Fixed embryos were sent to the Molecular Pathology 
Core Facility at Robarts Research Institute (London, ON) for sectioning.  Slides were 
washed in xylene for 15 minutes to deparaffinize sections.  Embryo sections were 
gradually rehydrated with ethanol and 1x PBST (1x phosphate-buffered saline + 0.1% 
Triton-X (Sigma)) by 5 minute incubations in 100% ethanol, 90% ethanol + 10% 1x 
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PBST, 80% ethanol + 20% 1x PBST, and 100% 1x PBST.  Sections were blocked with 
10% goat serum in 1x PBST for 45 minutes.  Primary antibody (rabbit anti-RECK 
(Genetex, Irvine, CA) and rabbit anti-β-catenin (Life Technologies)) at a 1:50 dilution 
was added to 2% BSA in 1x PBST and sections were incubated for 2 hours.  Sections 
were washed with 1x PBST for 5 minutes and a fluorescent-labeled secondary antibody 
(Alexa Fluor Goat Anti-Rabbit IgG) (Life Technologies) was added to 2% BSA in 1x 
PBST at a 1:200 dilution and sections were incubated for 1 hour.  Sections were washed 
in 1x PBST for 5 minutes and treated with 4', 6-diamidino-2-phenylindole (DAPI) (Life 
Technologies) in 1x PBST at a dilution of 1:4000 for 5 minutes, followed by a wash with 
1x PBST for 5 minutes.  Sections were rinsed with double distilled H2O and mounted 
using 50 µL of ProLong Gold antifade reagent (Life Technologies).  The slides were 
visualized using a Zeiss LSM 5 Duo confocal microscope at the Biotron (Western 
University). 
2.7 Lithium chloride treatment of early X. laevis embryos 
To investigate changes in RECK expression as a result of altering dorso-ventral 
axis patterning in X. laevis embryos, dorsalization was induced.  Embryos at stage 6 (32-
cell stage) were treated with 0.3M lithium chloride in 0.1x MMR for 10 minutes, rinsed 3 
times with 0.1x MMR, and transferred to a fresh petri dish containing 0.1x MMR.  
Embryos were maintained in 0.1x MMR until the desired developmental stage was 
reached.  Phenotypes were examined using the Dorsoanterior Index (DAI) Scale (Kao 
and Elinson, 1988).  Total RNA was isolated from treated and non-treated embryos at 
stages 20, 30, and 40 and RT-PCR was performed as previously described.  The 
experiment was repeated 3 times.       
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2.8 Ultraviolet light treatment of early X. laevis embryos  
To investigate changes in RECK expression as a result of altering dorso-ventral 
axis patterning in X. laevis embryos, ventralization was induced.  Prior to cortical 
rotation, embryos at stage 1 (1-cell stage) were exposed to 254 nm UV light at 2500 
µW/s/cm2 for 3 minutes using a Benchtop 3UVTM Transilluminator (UVP, Upland, CA).  
Embryos were maintained in 0.1x MMR until the desired developmental stage was 
reached.  Phenotypes were assessed using the DAI Scale (Kao and Elinson, 1988).  Total 
RNA was isolated from treated and non-treated embryos at stages 20, 30, and 40 and RT-























3.1 Cloning of X. laevis RECK 
The mature RECK protein sequence (lacking the signal peptide and GPI-
anchoring signal) was chosen to be cloned in this study as preliminary studies show low 
conservation of the N- and C-terminal domains of RECK proteins among species.  
Furthermore, the X. laevis database is not fully annotated.  As such, primers were chosen 
flanking known functional domains of RECK.  The mature coding region of X. laevis 
RECK was amplified from adult intestinal tissue by PCR using primers designed against 
the X. tropicalis RECK sequence obtained online (see Materials and Methods for the 
accession number and primer sequences).  Derived X. laevis RECK was amplified, 
sequenced, and compared to RECK sequences from a variety of other organisms to 
confirm its identity.  Xenopus laevis RECK had a full-length coding region of 2, 532 base 
pairs and a protein length of 843 amino acids. 
To confirm that the newly cloned X. laevis RECK sequence contains all of the 
hallmark domains, sequence analyses were performed comparing RECK protein 
sequences of vertebrate and invertebrate species to the H. sapiens sequence.  Alignment 
scores yielded the following order of similarity to H. sapiens: C. familiaris, M. musculus, 
G. gallus, X. laevis, O. niloticus, and D. melanogaster (Table 3).  Compared to human, 
the most highly similar RECK protein sequence is dog, at 95%, and the least similar 
RECK protein sequence is fruit fly, at 31% (Table 3).  Known domains of RECK were 





Table 3.  
 
Full length RECK protein amino acid sequence similarity scores as ranked with H. 
sapiens 
Species Percent Similarity Accession 
Number 
Homo sapiens 100% NP_066934 
Canis lupis familiaris 95% NP_001002985 
Mus musculus 93% NP_057887 
Gallus gallus 84% XP_418897 
Xenopus laevis 78% N/A 
Oreochromis niloticus 58% XP_003457562 













The middle portion of all well characterized RECK proteins contain three Kazal 
motifs (serine-protease inhibitor-like domains).  Compared to human, the Kazal motif 
domains of vertebrate RECK sequences share high similarity, whereas invertebrate 
RECK sequences share low similarity (Table 4).  Moreover, Kazal motif 1 and 3 of X. 
laevis RECK sequence share 85% and 86% similarity to human, respectively (Table 4).  
Kazal motif 2 is less similar among species, and as such, Kazal motif 2 of X. laevis 
RECK sequence shares only 65% similarity to human RECK (Table 4).  
The middle portion of RECK also contains two epidermal growth factor (EGF)-
like repeats.  Compared to human, the EGF-like repeats of vertebrate RECK sequences 
share high similarity (>62%), whereas invertebrate RECK sequences share low similarity 
(<32%) (Table 5).  The first EGF-like repeat of X. laevis RECK sequence shares 87% 
similarity to H. sapiens RECK, whereas the second EGF-like repeat of X. laevis RECK 
shares only 65% similarity with H. sapiens RECK (Table 5). 
3.2 Clustalw2 analysis of X. laevis RECK revealed sequence conservation among 
vertebrate species 
 To further identify similarities of RECK proteins among a variety of species, a 
phylogram was generated using Clustalw2 software (Figure 5).  RECK protein sequences 
used for this analysis were from the following species: H. sapiens, C. familiaris, M. 
musculus, C. familiaris, G. gallus, X. laevis, O. niloticus, and D. melanogaster.  Sequence 
analysis placed X. laevis RECK as more closely related to chicken, mouse, dog, and 




Table 4.  
 
Conservation of the amino acid sequence of the three Kazal motif domains of RECK as 
ranked with H. sapiens (percent similarity)  






Homo sapiens 100% 100% 100% 
Canis lupis familiaris 98% 86% 94% 
Mus musculus 93% 88% 94% 
Gallus gallus 93% 77% 89% 
Xenopus laevis 85% 65% 86% 
Oreochromis niloticus 65% 47% 69% 
Drosophila melanogaster 50% 16% 51% 
 
Table 5.  
 
Conservation of the amino acid sequence of the two epidermal growth factor (EGF)-like 
repeats of RECK as ranked with H. sapiens (percent similarity) 
Species EGF-like repeat 1 EGF-like repeat 2 
Homo sapiens 100% 100% 
Canis lupis familiaris 94% 94% 
Mus musculus 90% 88% 
Gallus gallus 81% 82% 
Xenopus laevis 87% 65% 
Oreochromis niloticus 65% 62% 




Sequence analysis of RECK.  Sequence comparison showing relative similarity of 
RECK protein was performed using Clustalw2 analysis software at the European 
Bioinformatics Institute site at www.ebi.ac.uk/Tools/msa/clustalw2/ using default 
settings.  The following are proteins and accession numbers used for this analysis: Homo 
sapiens (NP_066934), Canis lupis familiaris (NP_001002985), Mus musculus 
(NP_057887), Gallus gallus (XP_418897), Oreochromis niloticus (XP_003457562), 







































3.3 RT-PCR analysis of X. laevis RECK transcript levels during early development 
 In order to examine the temporal expression pattern of RECK during early 
development, semi-quantitative PCR was performed.  Developmental stages chosen to be 
analyzed included gastrulation (stage 10), closure of the neural tube (stage 18), further 
neural elongation (stage 24), and organogenesis (stages 32, 37, and 40).  RECK mRNA 
levels were measured relative to EF1α, a housekeeping gene that maintains consistent 
levels throughout development (Rupp and Weintraub, 1991; Monsoro-Burq et al., 2003).  
RECK levels were present at all stages throughout early development (Figure 6).  RECK 
transcript levels were low during gastrulation (stage 10) and increased during neurulation 
(stage 18).  During later stages of development (stages 24, 32, 37, and 40), RECK 
transcripts maintained relatively consistent levels.   
3.4 RT-PCR analysis of X. laevis TIMP-2 transcript levels during early development 
 The temporal expression of TIMP-2 was also examined during early development 
to determine if TIMP-2 followed a similar expression pattern to RECK.  TIMP-2 mRNA 
levels were measured relative to EF1α.  TIMP-2 transcript levels were not present during 
gastrulation (stage 10), but gradually increased during neurulation (stage 20) and 
organogenesis (stage 30-40) (Figure 7). 
3.5 Whole mount in situ hybridization of X. laevis RECK during early development 
 Semi-quantitative PCR analysis revealed that RECK transcript levels do not peak 
until neurulation.  As such, a DIG-labeled anti-sense RNA probe was used to detect 




Temporal expression analysis of RECK mRNA levels during early X. laevis 
development. RT-PCR analysis of RECK transcripts measured relative to EF1α was 
performed on embryos at stages 10 through to 40.  RECK expression is low early on in 
development during gastrulation (stage 10) and increases during neurulation (stage 18 to 
24) and into organogenesis (stages 32 to 40).  Standard error bars are representative of 




























































Temporal expression analysis of TIMP-2 mRNA levels during early X. laevis 
development. RT-PCR analysis of TIMP-2 transcripts measured relative to EF1α was 
performed on embryos at stages 10, 20, 30, and 40.  TIMP-2 transcripts are not detected 
until neurulation (stage 20).  TIMP-2 transcript levels slowly increase throughout 
organogenesis, peaking at stage 40.  Standard error bars are representative of three 

























































DIG-labeled anti-sense RNA  probe  for cardiac troponin 1, a  heart specific marker, was 
used as a positive control (Figure 8A), and no probe was used as a negative control 
(Figure 8B).  Results showed differential expression of RECK transcripts throughout 
development.  RECK expression was present in dorsal neural structures, including the 
neural tube, notochord, and brain at the late tailbud stage (stage 28) (Figure 9B,E).  
However, during later stages of organogenesis (stage 35), RECK expression was not 
detectable in the notochord but remained localized to the neural tube and brain (Figure 
9C).  Throughout development, RECK expression was strongly present in anterior 
structures such as the eye, branchial arches, and otic placode (Figure 9A-D).  Also of 
importance was the appearance of RECK transcripts on the ventral side of the embryos in 
the blood precursors at stage 35 (Figure 9C). 
3.6 Immunohistochemistry of RECK proteins in early X. laevis embryos 
 To further examine the expression pattern of RECK during early X. laevis 
development, immunohistochemistry was performed on sections of early tailbud embryos 
to detect RECK proteins.  RECK proteins were localized to punctate structures along the 
somites and along the dorsal side of the notochord in early tailbud embryos (Figure 10A).  
Punctate staining was also present in tissues in the head, including regions of the brain, 
eye, and cement gland (Figure 10B). RECK proteins were not detected along the neural 
tube of the embryo.  β-catenin was used as a positive control (Figure 10C).  
3.7 RT-PCR analysis of the effect of LiCl treatment on the expression level of RECK 
in X. laevis embryos  




Whole mount in situ hybridization of cardiac troponin 1 in early X. laevis embryos.  
Whole mount in situ hybridization of stage 28 embryos with antisense Digoxigenin-
labeled RNA probes against cardiac troponin 1 (A) was performed to establish 
specificity in the experiment.  The experiment was also performed without a probe as a 





































Spatial expression pattern of RECK mRNA during early X. laevis development.  
Whole mount in situ hybridization was performed on embryos at stages 23 (A), 28 (B), 
35 (C), and 38 (D) to determine spatial expression of RECK using antisense Digoxigenin-
labeled RNA probes against the amplicons of the Kazal motif domains (Table 1). Panel E 
is a magnified view of a cross section indicated in panel B.  RECK expression is strongly 
present in anterior structures such as the eye and otic placode throughout early 
development (A-D).  At late tailbud stage (B), RECK expression is present on dorsal 
neural structures such as the neural tube and notochord.  However, by stage 35 (C), 
RECK expression disappears from the notochord and appears in the blood precursors on 
the ventral side of the embryo.  Abbreviations: BA=branchial arches, BP=blood 




























Figure 10.   
Immunohistochemistry of RECK proteins in early X. laevis tailbud embryos (stage 
25).  Immunohistochemistry was performed using anti-RECK antibody on sections of 
early tailbud embryos.  Sections were counterstained with DAPI (blue).  (A) Squares on 
representative embryo represent the locations of histological sections in B and C. Scale 
bar: 1mm.  (B) RECK protein (green) is localized to anterior head regions such as the 
brain and eye. Scale bar: 100µm.  (C) RECK protein is also localized to the notochord 
and ventral somites. Scale bar: 100µm.  (D) Anti-β-catenin antibody was used as a 
positive control. Scale bar: 10µm.  Abbreviations: B=brain, S=somites, N=notochord, 

























development showed localization of RECK in dorsal and anterior structures.  To 
determine whether RECK levels change when dorso-ventral axis patterning is disrupted, 
X. laevis axis formation was perturbed.  Early embryos were treated with lithium chloride 
to induce dorsalization.  Dorsalized embryos with a DAI score of 8 were achieved.  
Dorsalized embryos completely lacked a trunk, had exaggerated heads and lacked ventral 
structures (Figure 11A) compared to untreated control embryos (Figure 11B).   
RNA was isolated from stages 20, 30, and 40 from LiCl-treated embryos and 
untreated control embryos and RT-PCR analysis was performed.  The expression levels 
of chordin, a well-established dorsal mesodermal marker, were measured to confirm 
dorsalization of LiCl-treated embryos.  Chordin transcript levels, measured relative to 
EF1α, were higher in LiCl-treated embryos compared to untreated control embryos at all 
stages examined (Figure 11C).  RECK expression levels were also measured relative to 
EF1α.  RECK levels were unchanged in LiCl-treated embryos relative to control embryos 
at all stages examined (Figure 11D).      
3.8 RT-PCR analysis of the effect of UV treatment on the expression level of RECK 
in X. laevis embryos  
 In dorsalized embryos, RECK expression levels did not change, however, I 
wanted to determine if RECK expression levels would increase in ventralized embryos.  
Prior to completion of the first cell cycle, embryos were exposed to UV light to induce 
ventralization.  Treated embryos were severely ventralized and had a DAI score of 0.  
Ventralized embryos were largely yolk-containing and completely lacked anterior and 




Semi-quantitative PCR analysis of chordin and RECK levels in lithium chloride-
treated X. laevis embryos.  LiCl-treated embryos were examined at stages 20, 30, and 
40.   RT-PCR analysis of chordin and RECK transcript levels measured relative to EF1α 
was performed on treated and non-treated embryos.  (A) Embryos treated with 0.3M LiCl 
for 10 minutes were dorsalized and displayed exaggerated heads and severely reduced 
trunks (stage 40 shown).  Scale bar: 1 mm.  (B) Embryos that were not treated developed 
normally (stage 40 shown).  Scale bar: 1 mm.  (C) Chordin transcript levels increased in 
LiCl-treated embryos compared to control embryos at all stages examined.  (D) No 
change in RECK transcript levels were seen at any of the stages examined.  Standard 



























control  embryos  were  maintained  under  the same  conditions and developed  normally 
(Figure 12B). 
RNA was isolated from stages 20, 30, and 40 from UV-treated embryos and 
untreated control embryos and RT-PCR analysis was performed.  The expression levels 
of chordin were measured to confirm ventralization of UV-treated embryos.  Chordin 
levels, measured relative to EF1α, were lower in UV-treated embryos compared to 
untreated control embryos at all stages examined (Figure 12C).  RECK expression levels 
were measured relative to EF1α.  RECK levels were unchanged in UV-treated embryos 
















Semi-quantitative PCR analysis of chordin and RECK levels in UV-treated X. laevis 
embryos.  UV-treated embryos were examined at stages 20, 30, and 40.   RT-PCR 
analysis of chordin and RECK transcript levels measured relative to EF1α was performed 
on treated and non-treated embryos.  (A) Embryos treated with UVC light for 3 minutes 
were severely ventralized, containing all yolk and completely lacking anterior and dorsal 
structures (stage 30 shown). Scale bar: 1 mm. (B) Embryos that were not treated 
developed normally (stage 30 shown).  Scale bar: 1 mm.  (C) Chordin transcript levels 
decreased in UV-treated embryos compared to control embryos at all stages examined.  
(D) No change in RECK transcript levels were seen at any of the stages examined.  











































 In this study, I cloned and characterized the mature coding region of X. laevis 
RECK and examined the expression pattern of RECK during early embryonic 
development.  Sequence analysis indicated that X. laevis RECK is evolutionarily 
conserved among vertebrates.  As discussed below, when the expression pattern of RECK 
was analyzed during early X. laevis development, RECK expression was low early on in 
development during gastrulation and increased during neurulation and into 
organogenesis.  Furthermore, RECK transcripts were localized to anterior and dorsal 
structures in early embryos.  
4.2 X. laevis RECK is highly similar with vertebrate RECK 
Proteins that share high sequence similarities among different species are usually 
considered evolutionarily significant and thus serve important functions (Giudice 2001).  
In this study, I chose to clone the mature X. laevis RECK sequence lacking the N- and C-
terminal domains, as these domains were found to be poorly conserved even within 
vertebrates.  Since these domains are not directly related to RECK function, their 
sequences could be variable between species.  Indeed, sequence analysis confirms this 
(see Appendix I).  While the N- and C-terminal domains are not highly conserved, the 
important functional domains should be.  As such, I focused on sequencing known 
functional domains of the RECK protein.   
The newly cloned X. laevis RECK protein sequence was compared to RECK 
protein sequences from a variety of other species.  Sequence analysis revealed that X. 
laevis RECK is highly similar to H. sapiens RECK.  Although a phylogenetic analysis of 
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RECK proteins has been performed in the past (Knorr et al., 2009), X. laevis RECK was 
not included in this comparison.  When RECK amino acid sequences from both 
vertebrates and invertebrates were aligned, the most related RECK sequences were 
human, dog, and mouse, and the least related RECK sequence was fruit fly.  Xenopus 
laevis RECK was found to share high similarity to mammalian and non-mammalian 
vertebrate species.  This result suggests that RECK proteins serve a similar role among 
different species. 
 Hallmark domains of RECK were further analyzed to determine conservation 
within RECK proteins that may reveal important functions.  For the most part, all 
domains of RECK were highly conserved among vertebrates.  As comparisons were 
made while phylogenetic distance increased, conservation of domains decreased; 
however, this pattern is often seen with other proteins and genes.  
 The three Kazal motifs of RECK were found to display an above average level of 
similarity between vertebrates and invertebrates compared to other domains.  As 
previously mentioned, the Kazal motifs are protease inhibitor-like domains, and as such, 
presumably play an important role in inhibiting MMPs.  Interestingly, Chang et al. (2008) 
determined that the Kazal motifs of RECK are important in inhibiting MMPs.  They 
generated recombinant proteins containing Kazal motifs 2 and 3 and found that these 
recombinant proteins inhibited MMPs when transfected into mouse lung cancer cells.  
Thus, the high conservation of Kazal motifs domains among vertebrates and invertebrates 
suggests a conservation of RECK function as an MMP inhibitor.      
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Overall, X. laevis RECK contains all of the hallmark motifs that are characteristic 
to RECK proteins.  The high overall amino acid sequence similarity between X. laevis 
and other vertebrate RECK proteins suggests a conservation of function.  Indeed, studies 
have shown a correlation of RECK function between species. Oh et al. (2001) and 
Prendergast et al. (2012) discovered impaired vascular development in RECK-deficient 
mouse and zebrafish embryos, respectively. 
4.3 RECK mRNA levels correlate with ECM remodeling events during X. laevis 
development 
 RECK mRNA expression was examined during various stages of early X. laevis 
development.  This was done to identify possible correlations between RECK expression, 
known functions related to regulation of ECM remodeling and cell migration, and 
developmental events known to involve extensive ECM remodeling.  When temporal 
data were examined, interestingly, results showed that RECK expression was low during 
gastrulation, a developmental event that requires extensive ECM remodeling (Urry et al., 
1998; Pickard and Damjanovski, 2004).  This result suggests that RECK does not play a 
role in regulating ECM remodeling during gastrulation.  Likely other MMP inhibitors, 
such as TIMP-3, which is known to be present at this time (Pickard and Damjanovski, 
2004), tightly regulate large-scale ECM turnover events that are occurring during 
development.    
 RECK expression was more readily detectable at stage 18, during which time the 
neural tube closed, and RECK levels remained relatively elevated all the way through to 
stage 40, during which time axis elongation was occurring and organs began to develop.  
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Neurulation and organogenesis also require extensive ECM remodeling (Urry et al., 
1998; Pickard and Damjanovski, 2004), but here remodeling becomes increasingly more 
localized and refined.  Damjanovski et al. (2000) revealed distinct spatial distribution 
patterns of several MMP mRNAs throughout the developing embryo.  Perhaps RECK is 
present at high levels during neurulation and organogenesis to regulate MMP activity, 
ensuring proper components of the ECM are being remodeled to allow for controlled 
local cell migration.  For instance, Prendergast et al. (2012) revealed that RECK 
expression was required for the differentiation of neural crest cells in zebrafish embryos, 
a process that occurs following closure of the neural tube.  Moreover, Oh et al. (2001) 
discovered the importance of RECK during vascular development in mouse embryos.  
Although research is limited, a previous study by Knorr et al. (2009) revealed 
high levels of RECK mRNA expression during early development of the red flour beetle, 
Tribolium castaneum.  RECK levels were high throughout the pupal stage, during which 
time the beetle undergoes metamorphosis.  This event requires precise local ECM 
remodeling, so perhaps RECK is expressed during these stages to regulate MMP activity 
and thus ECM remodeling.   
Interestingly, TIMP-2, a well-characterized MMP inhibitor, also follows a similar 
expression pattern during early X. laevis development.  TIMP-2 transcripts were not 
present during gastrulation; however, TIMP-2 transcripts increased during neurulation 
and organogenesis.  Since RECK and TIMP-2 share similar mRNA expression patterns, 
perhaps their role in development is linked.  Indeed, TIMP-2 indirectly upregulates 
RECK by binding its C-terminal domain to α3β1 integrins on the surface of human 
endothelial cells (Oh et al., 2004).  
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The expression pattern of RECK during early development revealed that RECK is 
expressed at increased levels during given stages of development that require extensive 
ECM remodeling (such as neurulation and organogenesis).  Perhaps RECK function at 
these stages is regulated and mitigated by other inhibitors such that RECK plays an 
accessory role with respect to TIMP-2. Moreover, perhaps RECK plays a role in 
protecting structures from undergoing excessive ECM remodeling by regulating MMP 
activity and that this role increases as differentiation is occurring.  For example, 
Chandana et al. (2010) suggested that RECK may play a protective role during vascular 
development in mice. When histological sections of head and liver of RECK-deficient 
mice were examined, blood vessels appeared abnormally large and irregularly shaped.  
These results suggested that RECK protects blood vessels from fusing together and 
instead facilitates branching (Chandana et al., 2010).  
4.4 RECK transcripts are localized to anterior and dorsal structures in X. laevis 
embryos 
To further examine RECK expression during early X. laevis development, whole 
mount in situ hybridization was performed on early embryos.  RECK mRNA was 
abundantly expressed in anterior and dorsal structures of the embryo, including the neural 
tube, notochord, and brain.  Prendergast et al. (2012) also performed whole mount in situ 
hybridization to detect RECK transcripts in developing zebrafish embryos.  The pattern of 




A number of MMP mRNAs are localized along the dorsal axis of X. laevis 
embryos (Damjanovski et al., 2000).  Perhaps RECK is present in precise dorsal 
structures to control MMP activity and thus regulate proper ECM remodeling associated 
with specific cellular events such as cell migration.  For example, Prendergast et al. 
(2012) detected RECK mRNA in neural crest cells of early zebrafish embryos.  Their 
results suggested that expression of RECK in neural crest cells was necessary to regulate 
proper formation of DRG, a process that requires cell migration.           
Interestingly, RECK was transiently expressed in the notochord, as expression 
disappeared late in development during which extensive cell death events are occurring in 
the notochord.  Type II collagen mRNA surrounds the notochord (Bieker and Yazdani-
Buicky, 1992), and for axis elongation to occur as the embryo grows, these many large 
structural proteins such as collagen have to be degraded.  The expression pattern of 
RECK suggests that RECK is involved in early specific developmental events such as 
neurulation and is likely less involved in more large scale ECM remodeling events such 
as those that occur during axis elongation.  Therefore, it is not surprising that RECK is 
absent in late notochord apoptosis and axis elongation events.  In fact, Prendergast et al. 
(2012) also found transient RECK expression on the dorsal side of zebrafish embryos.  
Furthermore, as previously mentioned, RECK is required for the differentiation of neural 
crest cells in zebrafish embryos (Prendergast et al., 2012), a process that occurs early in 
development following neural tube closure.     
 RECK expression was also abundant in the head region, such as the eye and otic 
vesicles, throughout the stages examined.  Formation of these organs requires extensive 
cell movements and controlled ECM remodeling (Saha et al., 1989; Grainger 1992).  Any 
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disruption in the balance between the levels of MMPs and inhibitors during development 
can cause developmental defects.  For example, overexpression of TIMP-3 mRNA, 
known to be expressed in the eye of X. laevis embryos, caused abnormalities in eye 
formation (Pickard and Damjanovski, 2004).  Perhaps RECK is present along with other 
MMP inhibitors during the formation of these organs to ensure proper development.   
RECK expression was also abundant in the head region of the late embryo as it is 
preparing to filter feed.  During these stages, extensive but specific ECM remodeling is 
required for the opening of the mouth, formation of the nasal pitts, and branching of the 
branchial arches (Nieuwkoop and Faber, 1956).  All of these processes occur in different 
regions of the head and require localized ECM remodeling events, thus, there are no 
global ECM degradation events occurring at this time.  Perhaps RECK regulates localized 
cell migration events rather than global events.  Furthermore, MMPs are expressed in a 
tissue specific manner during development.  For example, MMP-11 mRNA is abundantly 
present in the branchial arches in X. laevis embryos, and less so in the eyes and otic 
vesicles, whereas MMP-18 mRNA expression is abundant in the ventral head region in X. 
laevis embryos in an area where the opening to the mouth is forming (Damjanovski et al., 
2000).  Perhaps RECK expression is linked to the type of MMP that is expressed in a 
given tissue.  For example, in mice, RECK is expressed in lung tissue along with high 
levels of MMP-2 and MT1-MMP transcripts (Nuttall et al., 2004).  Since RECK has 
previously been shown to inhibit MMP-2 and MT1-MMP activity, perhaps its role in 
lung tissue is to control ECM remodeling by regulating MMP-2 and MT1-MMP.   
 Interestingly, RECK expression was also present on the ventral side of the embryo 
during later stages of development when blood precursors form.  Perhaps RECK is 
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involved in blood differentiation on the ventral side of the embryo.  As well, the presence 
of RECK in the branchial arches suggests that RECK may play a role in the branching of 
blood vessels.  For example, as previously mentioned, Oh et al. (2001) revealed that 
RECK-deficient mouse embryos displayed enlarged blood vessels and abdominal 
hemorrhaging.  
Also of importance was the absence of RECK expression in specific tissues of the 
developing embryo such as the heart and intestine.  While the formation of these tissues 
also requires specific and extensive ECM remodeling, the absence of RECK suggests that 
RECK is not required to regulate MMP activity in these tissues.  As such, other MMP 
inhibitors, such as TIMPs, may be expressed in these organs to tightly regulate MMP 
activity and ensure proper development.  As well, the development of heart and intestine 
organs involves looping mechanisms, while vascular development, such as the formation 
of gills, involves branching mechanisms.  Perhaps RECK plays an important role in 
regulating ECM remodeling events that are linked to branching mechanisms.  In fact, in 
mouse embryos, RECK transcripts were most abundantly expressed in lung, in which 
development is characterized by branching of the bronchioles (Nutall et al., 2004).  
4.5 RECK protein localization in early X. laevis tailbud embryos 
To further analyze RECK, localization of RECK proteins was examined in early 
tailbud embryos (stage 25) by immunohistochemistry.  The presence of RECK proteins in 
the notochord is in accordance with in situ data and further indicates a need for RECK in 
the differentiation of neural structures at early tailbud stages.    However, contrary to in 
situ data, RECK proteins were not detected along the neural tube of early tailbud 
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embryos.  Although RECK transcripts appeared to localize in the neural tube throughout 
the developing embryo, perhaps RECK is regulated primarily at the protein level.  Thus, 
at this stage, ECM remodeling events that require RECK expression have already passed 
with respect to neural development.   
RECK proteins were also detected in the eye and brain regions in early tailbud 
embryos.  These results further support in situ data and suggest the importance of RECK 
expression in these developing tissues to regulate ECM remodeling.   
4.6 RECK transcript levels are unchanged in dorsalized and ventralized X. laevis 
embryos 
 To establish that RECK mRNA was localized primarily to dorsal and anterior 
structures in tailbud embryos, embryo development was perturbed with LiCl and UV 
treatment.  Contrary to my prediction, RECK mRNA levels did not change following 
dorsalization or ventralization of embryos.  These results could be due to the fact that 
RECK mRNA appeared on ventral structures of the developing embryo as well, although 
expression appeared to be more abundant on the dorsal side of the embryo.  RECK 
expression may change between tissues, where there is large-scale decreases of RECK in 
one area of the embryo and increases in another, however, analysis of total embryonic 
RECK levels do not reflect such changes.  Thus, total RECK RNA levels remain 
relatively constant while relative dorsal and ventral levels change.  As such, when axis 
formation was perturbed, RECK mRNA levels appeared relatively unchanged.  Another 
possibility could be that RECK is regulated at the protein level, and thus changes in 
dorso-ventral axis patterning alters RECK protein levels.  For instance, RECK has been 
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shown to be regulated at the post-translational level through glycosylation of asparagine 
sites (Simizu et al., 2005). 
4.7 Conclusions 
1) X. laevis RECK protein is highly similar to RECK proteins from other species of 
vertebrates 
2) X. laevis RECK mRNA levels correlate with specific late ECM remodeling events 
during development. 
3) X. laevis RECK localizes to dorsal neural structures in the developing embryo. 
4) Axis perturbation of early embryos does not affect global RECK mRNA 
expression levels in the whole embryo.   
4.8 General summary and future perspectives 
 In the present study, X. laevis RECK was cloned and its expression profile was 
examined during early X. laevis development.  Xenopus laevis RECK was found to share 
high similarity to human RECK.  Further sequence analysis revealed that RECK domains 
were highly conserved among vertebrates, suggesting that RECK proteins serve similar 
functions in different species.  Expression analysis of RECK during early X. laevis 
development revealed that RECK is present during given ECM remodeling events, such 
as neurulation and organogenesis.  Its downregulation during other important events, such 
as gastrulation and axis elongation, indicate the importance of regulating RECK during 
early X. laevis development.  Axis perturbation in early embryos did not affect RECK 
mRNA levels, suggesting that RECK expression is tissue specific.  Altogether, this study 
was the first detailed comprehensive characterization of RECK during early vertebrate 
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development and helped elucidate the role RECK plays in mediating ECM turnover 
during development. 
 Future work analyzing RECK protein expression throughout X. laevis 
development would further identify the role RECK plays during embryonic development.  
Moreover, overexpression and knockdown experiments of RECK in X. laevis embryos 
would further elucidate RECK function during early development and may reveal what 
types of ECM remodeling events RECK regulates.  As MMP activity is high during 
development, X. laevis is an ideal model for studying the in vivo interaction of RECK and 
MMPs.  As such, it would also be interesting to measure aberrant MMP activity 
following overexpression or knockdown of RECK. 
Overall, this research allows for a better understanding into how RECK functions 
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Conservation of the amino acid sequence of the N-terminal hydrophobic region (signal 
peptide) of RECK as ranked with H. sapiens 
Species Percent Similarity Accession 
Number 
Homo sapiens 100% NP_066934 
Canis lupis familiaris 88% NP_001002985 
Mus musculus 81% NP_057887 
Gallus gallus 12% XP_418897 
Xenopus laevis N/A N/A 
Oreochromis niloticus 27% XP_003457562 
Drosophila melanogaster 8% NP_648733 
Conservation of the amino acid sequence of the C-terminal hydrophobic region 
(glycosylphosphatidylinositol anchoring signal) of RECK as ranked with H. sapiens 
Species Percent Similarity Accession 
Number 
Homo sapiens 100% NP_066934 
Canis lupis familiaris 59% NP_001002985 
Mus musculus 59% NP_057887 
Gallus gallus 21% XP_418897 
Xenopus laevis N/A N/A 
Oreochromis niloticus 14% XP_003457562 




Predicted Xenopus laevis RECK Protein Sequence 
M C R D V C E Q I L S S K S E S R I K H L L L R A P D Y C P T S M I D V W T C I 
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Multiple sequence alignment using ClustalW2 of RECK protein sequences from various 
species* 
*Homo sapiens (NP_066934), Canis lupis familiaris (NP_001002985), Mus musculus 
(NP_057887), Gallus gallus (XP_418897), Xenopus laevis, Oreochromis niloticus 
(XP_003457562), and Drosophila melanogaster (NP_648733). 
 
Homo           ------------------------------------------------------------ 
Canis          ------------------------------------------------------------ 
Mus            ------------------------------------------------------------ 
Gallus         ------------------------------------------------------------ 
Xenopus        ------------------------------------------------------------ 
Oreochromis    --------------------------------------------------MENMLSLLGP 10 
Drosophila     MRLSGWEILLFLLPFGVVSAVRQLEENQSIKNDHHHSVERQVRRRNNKSNASVDHHRHAP 60 
                                                                              
 
Homo           ---------------MATVRASLRGALLLLLAVAGVAEVAGGLAPGSAGALCCNHSKDNQ 45 
Canis          ---------------MAAVPASPRGALLLLLAVAGVAEVAGGLAPGSAGALCCNHSKDNQ 45 
Mus            ---------------MASVRASPRSALLLLLAAAGVAEVTGGLAPGSAGAVCCNHSKDNQ 45 
Gallus         -----------------------------------MTEVAD-LNHRTKCLSCCYHAKDNL 24 
Xenopus        ------------------------------------------------------------ 
Oreochromis    DDGGFLFAHLFLRQLPAAVRAVLANSPLLPAKDYRFLAEEADRILLASHPSCCHHAAEFS 70 
Drosophila     SSGSKKNSRSHSVSLDSDDYDWLDADTSEAIDSSEVTAVESIRSPGESYDIFTCCNQVFG 120 
                                                                              
 
Homo           MCRDVCEQIFSSKSES-RLKHLLQRAPDYCPETMVEIWNCMNSSLPGVFKKSDGWVGLGC 104 
Canis          MCHDVCEQIFSSKSES-RLKHLLQRAPDYCPETMVEIWSCMNSSLPGVFKKSDGWVGLGC 104 
Mus            MCRDVCEQIFSSKSES-RLKHLLQRAPDYCPETMVEIWSCMNSSLPGVFKKSDGWVGLGC 104 
Gallus         MCRDVCEQILSSKSDS-RLKHLLQRAPEYCPESMGEVWGCINSSLPGVLKKSDGWVGLGC 83 
Xenopus        MCRDVCEQILSSKSES-RIKHLLLRAPDYCPTSMIDVWTCINSSLPGVSKKSEGWVGLGC 59 
Oreochromis    PCREACDQLTTIKSES-RLKHLLQRLPGYCSESMNELWMCINSTLPGVSRKSEGWVGLGC 129 
Drosophila     SCRTACENLSLVEFATGTGGDNRDELHRYCQLHQVEFWTCVNQTFDAITRGAD-WSGRRC 179 
                *: .*:::   :  :    .   .   **     :.* *:*.:: .: : :: * *  * 
 
Homo           CELAIALECRQACKQASSKNDISKVCRKEYENALFSCISRNEMGSVCCSYAGHHTNCREY 164 
Canis          CELAITLECRQACKQASSKNDISKACRKEYENALFSCISRNEMGSVCCSYAGHHTNCREY 164 
Mus            CELAIGLECRQACKQASSKNDISKVCRKEYENALFSCISRNEMGSVCCSYAGHHTNCREF 164 
Gallus         CELAIAVECRQACKQASSKNDILKVCRKEYENALFSCINRNEMGSICCSYAGHHTNCREY 143 
Xenopus        CELAIAVECRRACKQASSQNDISKSCRKQYETALISCINRNEMGSVCCSYAGRHTNCREY 119 
Oreochromis    CELAITTECRKECKQASSKNDITKVCKKTTENSLYSCITKNEMGSTCCSYAGRHTTCREY 189 
Drosophila     CQFGVLPHCRNVCATSTRSP--VQNCRRSDEQTLYDCLERQEAADQCCGQA-RTSECLEA 236 
               *::.:  .**. *  :: .    : *::  * :* .*: ::* .. **. * : : * *  
 
Homo           CQAIFRTDSSPGPSQIKAVENYCASISPQLIHCVNNYTQSYPMRNPTDSLYCCDRAEDHA 224 
Canis          CQAIFRTDSSPGPSQIKAVENYCASISPQLIHCVNNYTQSYPMRNPTDSLYCCDRAEDHA 224 
Mus            CQAIFRTDSSPGPSQIKAVENYCASISPQLIHCVNNYTQSYPMRNPTDSLYCCDRAEDHA 224 
Gallus         CQAIFRTDSSPGPSQIKAVENYCASISPQLIHCVNNYTQSYPMRNPTDSLYCCDRAEDYA 203 
Xenopus        CQAIFRTDSSPGPSQIKAVENFCASISPPLVQCVNNYTQSYPMRNPVDSLYCCDRAEDPQ 179 
Oreochromis    CQAIFRTDSTPTVSQISAVKDYCQTHSAQLIHCVNNFTKSYPIHSPVDSLYCCDRAATH- 248 
Drosophila     CRAVFEPANDN--HDHVDINGACGDRNADVIQCVNNHTDMTPLANAEQYIPCCEYSSKEH 294 









Homo           CQNACKRILMS----KKTEMEIVDGLIEGCKTQPLPQDPLWQCFLESSQSVHPGVTV--- 277 
Canis          CQNACKRILMS----KKTEMEIVDGLIEGCKTQPLPQDPLWQCFLESSQSVHPGVTL--- 277 
Mus            CQNACKRILMS----KKTEMEIVDGLIEGCKTQPLPQDPLWQCFLESSQSVHPGVTV--- 277 
Gallus         CQTACKRILMS----MKTELEIVDGLIEGCKTMPLPQDPLWQCFLESSRSVHPGVTV--- 256 
Xenopus        CQSACKRILMS----KKTEPEIVDSLSEGC-TKPLPQDPLWQCFLESSRTVHSGVNI--- 231 
Oreochromis    CQMACRQILRT----MSTEHEIMEGLIKECGSQPLPQEPMWQCFLSSVQ--TPSITP--- 299 
Drosophila     CRHTCRNLLHQNATLMERSEVIFGRLEAAGCGSPLPQLPFWQCFLTVTGKLYVPGGSGRA 354 
                *: :*:.:*       . .  *.  *       **** *:*****                
 
Homo           ----------------HPPPSTGLDGAKLHCCSKANTSTCRELCTKLYSMSWGNTQSWQE 321 
Canis          ----------------HPPPSTGLDGAKLHCCSKANTSTCRELCTKLYSMSWGNTQSWQE 321 
Mus            ----------------HPPPSTGLDGAKLHCCSKANTSTCRELCTKLYSMSWGNTQSWQE 321 
Gallus         ----------------HPPPSTGLDGAKLHCCSKANSSTCRELCTKLYSTSWGSSQSWQE 300 
Xenopus        ----------------VPPPSAGLDGAELHCCSKANSSNCRDLCTKLYSTSWGNTQVWQE 275 
Oreochromis    ----------------EDNLPAKMDCAKLHCCSKANTSLCRDMCLEISSN-WG-SQTWQD 341 
Drosophila     GGSLAQGRISGQGGSLAEPNHLGMDAAKRQCCEQASSHKCRRLCNQIFTSNWWDAR--SS 412 
                                      :* *: :**.:*.:  ** :* :: :  *  ::  .. 
 
Homo           FDRFCEYNPVEVSMLTCLADVREPCQLGCRNLTYCTNFNNRPTELFRSCNAQSDQGAMND 381 
Canis          FDRFCEYNPVEVSMLTCLADVREPCQLGCRNLTYCTNFNNRPTELFRSCNAQSDQGAMND 381 
Mus            FDRICEYNPVEVSMLTCLADVREPCQLGCTNLTYCTNFNNRPTELFRSCTAQSDQGAMSD 381 
Gallus         FDRFCEYNAVEVSMLTCLADVREPCQLGCRNLSYCTNFNNRPTELFRSCNSQSDQGAMND 360 
Xenopus        FEFACEYNPLEAPMLTCLADVREPCQLGCRNLTFCTNFNNRPTELFRSCNVQSDQGAMND 335 
Oreochromis    FDQLCEYNPVETELINCLADVREPCQLGCKDLTYCTNFNNRPTELFRSCNIQSDQGAMND 401 
Drosophila     FENECMDQPGERELRRCIESVDAPCELGCQGLSFCSNFNNRPTELFRSCTPEHDAAARED 472 
               *:  *  :. *  :  *: .*  **:*** .*::*:*************. : * .* .* 
 
Homo           MKLWE-KGSIKMPFINIPVLDIKKCQPEMWKAIACSLQIKPCHSKSRGSIICKSDCVEIL 440 
Canis          MKLWE-KGSIKMPFINIPVLDIKKCQPEMWKAIACSLQIKPCHSKSRGSIICKSDCVEIL 440 
Mus            MKLWE-KGSIKMPFISIPVLDIKTCQPEMWKAVACSLQIKPCHSKSRGSIICKSDCVEIL 440 
Gallus         MKLWE-KGSIKMPFINIPVLDINKCQPEMWKAIACSLQIKPCHSKSRGSIICKSDCVEIL 419 
Xenopus        MKLWE-KGSIKMPFMNIPVLDIKKCHPEMWKAIACSLQIKPCHSKSRGSIICKTDCVEIL 394 
Oreochromis    IKLWS-NGTIKMPFMNIPVLDIRKCQPHMWKAVACSLQIKPCHSRSRGSVICKSDCVDIL 460 
Drosophila     WQLLQQRGTVRVLGQELFIKNTSRCAPDKWRALVCALQLKPCTRVGLFNGICSEDCHELL 532 
                :* . .*::::   .: : :   * *. *:*:.*:**:***   .  . **. ** ::* 
 
Homo           KKCGDQNKFPEDHTAESICELLSPTDDLKN---CIPLDTYLRPSTLG-NIVEEVTHPCNP 496 
Canis          KKCGDQNKFPEDHTAESICELLSPTDDLEN---CIPLDTYLRPSTLG-NIVEEVTHPCNP 496 
Mus            KKCGDQNKFPEEHTAESICEFLSPADDLES---CIPLDTYLRPSALG-NIIEEVTHPCNP 496 
Gallus         KKCGDHNKFPEGHTAESICELLSPTDDLEN---CIPLDTYLSPSSLG-NIVEDVTHPCNP 475 
Xenopus        TKCGDHSRFPESHTAESICELLSPSDENED---CIPLDTYLRSSPLD-NAIEEVTHPCNP 450 
Oreochromis    TQCGDTKRFHEGQTPERICELLSPIDDPEH---CIPLYKYLTPSSLGTNTVEEVIHPCNP 517 
Drosophila     DECLDWT--LQHQRPKDICSRLKEKDDDDSPLPCISLESYLKPGDASPEEFQGITSPCAQ 590 
                :* * .   : : .: **. *.  *: .    **.* .** ..  . : .: :  **   
 
Homo           NPCPANELCEVNRKGCPSGDPCLPYFCVQGCKLGEASDFIVRQGTLIQVPSS-------- 548 
Canis          NPCPANELCEVNRKGCLSGDPCLPYSCVQGCKLGEASDFIVRQGTLIQVPSS-------- 548 
Mus            NPCPANELCEVNRKGCPSADPCLPYSCVQGCKLGEASDFIVRQGTLIQVPSS-------- 548 
Gallus         NPCAANQLCEVNRKGCQSGELCLPYLCVPGCKLGEASDFIVRQGTLIQVPSS-------- 527 
Xenopus        NPCPANHLCEVNRKGCLPGEPCLPYFCSQGCKLGETSDFLVRHGVLIQMPS--------- 501 
Oreochromis    NPCPSNHICQVNRKGCLDELNCQPYLCVPGCKMGEASEFLVQQDARIQVPTR-------- 569 
Drosophila     KPCNGSEVCILQRGGNQG------YSCIPGCNLGQDSKLFVPFGSYVRLGKSNLHKKLEV 644 
               :** ...:* ::* *         * *  **::*: *.::*  .  ::: .          
 
Homo           -AGEVGCYKICSCGQSGLLENCMEMHCIDLQKSCIVGGKRKSHGTSFSIDCNVCSCFAGN 607 
Canis          -AGEVGCYKICSCGQSGLLENCMEMHCIDLQKSCIVGGKRKSHGTSFNIDCNICSCFAGN 607 
Mus            -AGEVGCYKICSCGQSGLLENCMEMHCIDLQKSCIVGGKRKSHGTSFTIDCNVCSCFAGN 607 
Gallus         -AGDVGCYKICTCGHTGLLENCVEMHCVDLQKSCIVGGQKKSHGTSFNIDCNVCSCFAGN 586 
Xenopus        --GSVGCYKICTCGQSGTLENCLDMQCVDLHKSCLVGGQRKNHGESFKVDCNICSCVAGT 559 
Oreochromis    -TDPTVCFEVCSCGPSGRLENCVEMPCMDTSKPCIVGGQRKSHGTSFKTDCHNCYCFAGE 628 
Drosophila     GQFPLAEHIVCSCGLQGRLEQCQPLPSYMHAHCTLPGARSYRHGSSFYLECNLCSCFAGE 704 






Homo           LVCSTRLCLSEHSSEDDRRTFTGLPCNCADQFVPVCGQNGRTYPSACIARCVGLQDHQFE 667 
Canis          LVCSTRLCLSEHSSEDDRRTFTGLPCNCADQFVPVCGQNGRTYPSACIARCVGLQDHQFE 667 
Mus            LVCSTRLCLSEHSSDDDRRTFTGLPCNCADQFVPVCAQNGRTYPSACIARCVGLQDHQFE 667 
Gallus         LICSTRQCLTEHSSEDERQKFTGLPCNCVDQFVPVCGQNGRTYPSACIARCVGLQDNQFE 646 
Xenopus        LRCSNHQCP---HSEEDRRMFTGLPCNCEDQFVPVCGQNGRTYPSACIARCVGLLDHQFE 616 
Oreochromis    TVCSTKECLSSGYTDDSHRHFTGLPCSCQDRFVPVCASNGRTYPSACVARCMGFKDSQFV 688 
Drosophila     ITCTKQQCRLPGFVDSG---YTSLPCNCPAHYVPVCGSNGNTYPSACVAKCH-LPEGDYV 760 
                 *:.: *      :.    :*.***.*  ::****..**.******:*:*  : : ::  
 
Homo           FGSCMSKDPCNPNP---CQKNQRCIPKPQVCLTTFDKFGCSQYECVPRQLACDQV-QDPV 723 
Canis          FGSCISKDPCNPNP---CPKNQRCIPKPQVCLTTFDKFGCNQYECLPRQLTCDQV-RDPV 723 
Mus            FGPCISKNPCNPNL---CPKSQRCVPKPQVCLTTFDKFGCSQYECVPRQLTCDQA-RDPV 723 
Gallus         FGSCISKDPCNPNP---CSKNQRCIPKKQVCLTSFGKFECSQHECVPRQLNCDQT-QDPV 702 
Xenopus        FGLCSS--VCNPNP---CSRNG--IPKRKVCLTSYEKFGCAQYECIPRHLKCEHS-RDPM 668 
Oreochromis    FGPCHLSKPCASKP---CQRNQRCIPKYRVCLS--DVSDCPQYECIGHAATCDKNSEDPA 743 
Drosophila     YGACNARNACQAAPPNSCPSGTQCLDSRKVCLASMQRPCLQYVCVNATASNCSTFHQGEV 820 
               :* *     * .     *  .   : . :***:                  *.   ..   
 
Homo           CDTDHMEHNNLCTLYQRGKS--LSYKGPCQP--FCRATEPVCGHNGETYSSVCAAYSDRV 779 
Canis          CDTNHMEHSNLCTLYQRGQS--LLYKGPCQP--FCRATEPICGHNGETYSSVCAAYSDRV 779 
Mus            CDTDHMEHSNLCTLYQRGKS--LSYRGPCQP--FCRAKEPVCGHNGETYSSVCAAYSDRV 779 
Gallus         CDTDSVEYSNVCTLYQKGKN--LAYRGPCQP--FCKSVEPVCGHNGETYSSVCAAYSDRV 758 
Xenopus        CDTENVEHINLCTLYQRGRL--LSYKGSCQP--FCKSAEPVCGHNGETYPNVCSAYSDRV 724 
Oreochromis    CDTEGMDHRSLCHLHQAGKT--LAYMGRCQE--ACRKPKQVCGHNGETYNTVCGAYSDRV 799 
Drosophila     CDSQGRTYPNACALLKANPQGQVAYWSACQSSRFNTSPSPVCGINGVTYKSSYAARAEYV 880 
               **::   : . * * : .    : * . **        . :** ** ** .  .* :: * 
 
Homo           AVDYYGDCQAVGVLSEHSSVAECASVKCPSLLAAGCKPIIPPGACCPLCAG-MLRVLFDK 838 
Canis          AVDYYGPCQAVGVLSEYGSVAECAAVKCPSLSVTECKPIIPPGACCPLCAG-MLRVLFDK 838 
Mus            AVDYYGPCQAVGVLSEYSAVAECAAVKCPSLSAIGCKPIIPPGACCPLCAG-MLRVLFDK 838 
Gallus         AVDYYGHCQAVGVLSDYGFHTECAFVKCPQLSATGCKPVIAPGACCPLCAG-MLRILYDK 817 
Xenopus        AVDYYGHCQDVGIFSDQGLHNECLSIQCPAIPVTVCKPIIPPGACCPLCAG-VLRILFDK 783 
Oreochromis    AVDYEAPCRAVGAVSDVAPDSACSLVSCPSLSTPGCHPVTPPGACCPICAS-ILQILWSK 858 
Drosophila     LVDYVGRCREVGLLVS-DMGRRCRTVKCPAPVSKHCRLIVPPGACCPLCAGGAFRIIYSR 939 
                *** . *: ** . .      *  :.**      *: : .******:**.  :::::.: 
 
Homo           EKLDTIAK---VTNKKPITVLEILQKIRMHVSVPQCDVFGYFSIESEIVILIIPVD--HY 893 
Canis          EKLDTIAK---VTNKKPITVLEILQKIRMHVSVPQCDVFGYFSIESEIVILIIPVD--HY 893 
Mus            EKLDTIAK---VTSKKPITVVEILQKVRMHVSVPQCDVFGYLSIESEIVILIIPVD--HY 893 
Gallus         DKLDNFAR---VTNKKPITVLDILEKLRLHVSVPQCDVFGYLSIESEIVILIIPVD--QK 872 
Xenopus        EKLDTFAT---ATKNTPITVMDILQKIRQHVSVPQCDVFGYLSMESDIIILIVPVD--SP 838 
Oreochromis    ERMNTFSK---VWTKQPVTVHDVLQILRPHISVPQCDVFGYLSIDHLLVVIIAPVD--QQ 913 
Drosophila     KQFDRAMYGLRAQSSTLLTLQGVLQQLDGLVQVSECQLTGFLTMEVGIFVAIVPSSSIKR 999 
               .:::       . ..  :*:  :*: :   :.*.:*:: *:::::  :.: * * .     
 
Homo           PKALQIEACNKEAEKIESLINSDSPTLASHVPLSALIISQVQVSSSVPSAGVRARPSCHS 953 
Canis          PKALQIEACIKEAEKIESLINSDSPTLASHVPLSALIISQVQISSSVPSAGIEARALCPS 953 
Mus            PKALQIEACNKEAEKIESLINSDSPTLASHVPLSALIISQVQVSSSLPSSAVVGRPLFHS 953 
Gallus         PKPLQIEACNKEAEKIESLINSDSPTLASHVPLSALIASQVQVSFSISSPSVKVGPVLHC 932 
Xenopus        PKSNH------------------------------------------------------- 843 
Oreochromis    PTPLQIEACSKEAEKIDSLINYASPTLVSHVPLSAFLTTEIKTSSIRSSGSTPSSPLTPA 973 
Drosophila     PTHLQLEACAREAEKISSLINAQSPRITTNLALSCLTVSHLLEPTPNGATSYGPHAIWIL 1059 
               *.  :                                                        
 
Homo           LLLPLSLGLALHLLWTYN 971 
Canis          YLLLLSLGPALHMVWIRN 971 
Mus            LLLLLSLGLTVHLLWTRP 971 
Gallus         LFISFSFTLLKLMDYI-- 948 
Xenopus        ------------------ 
Oreochromis    LCFLLGLLVTPAPVL--- 988 
Drosophila     PLLLLVSRVIIA------ 1071 
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